De novo design of high-affinity antibody variable regions (scFv) against the SARS-CoV-2 spike protein

BioRxiv : the Preprint Server for Biology
V. S. BoorlaCostas D Maranas


The emergence of SARS-CoV-2 is responsible for the pandemic of respiratory disease known as COVID-19, which emerged in the city of Wuhan, Hubei province, China in late 2019. Both vaccines and targeted therapeutics for treatment of this disease are currently lacking. Viral entry requires binding of the viral spike receptor binding domain (RBD) with the human angiotensin converting enzyme (ACE2). In an earlier paper, we report on the specific residue interactions underpinning this event. Here we report on the de novo computational design of high affinity antibody variable regions through the recombination of VDJ genes targeting the most solvent-exposed ACE2-binding residues of the SARS-CoV-2 spike protein using the software tool OptMAVEn-2.0. Subsequently, we carry out computational affinity maturation of the designed prototype variable regions through point mutations for improved binding with the target epitope. Immunogenicity was restricted by preferring designs that match sequences from a 9-mer library of human string content (HSC). We generated 60 different variable region designs and report in detail on the top five that trade-off the greatest affinity for the spike epitope (quantified using the Rosetta binding energies) wit...Continue Reading

Related Concepts

Transcriptional Regulation
Immunomagnetic Separation
Coloring Excipient
Ercc2 protein, mouse
Primary RNA Transcript
Gene Expression
Massively-Parallel Sequencing
Pharmaceutical Preparations

Related Feeds

BioRxiv & MedRxiv Preprints

BioRxiv and MedRxiv are the preprint servers for biology and health sciences respectively, operated by Cold Spring Harbor Laboratory. Here are the latest preprint articles (which are not peer-reviewed) from BioRxiv and MedRxiv.